%0 Journal Article
%A Leypoldt, Lisa B
%A Besemer, Britta
%A Asemissen, Anne Marie
%A Hänel, Mathias
%A Blau, Igor Wolfgang
%A Görner, Martin
%A Ko, Yon-Dschun
%A Reinhardt, Hans Christian
%A Staib, Peter
%A Mann, Christoph
%A Lutz, Raphael
%A Munder, Markus
%A Graeven, Ullrich
%A Peceny, Rudolf
%A Salwender, Hans
%A Jauch, Anna
%A Zago, Manola
%A Benner, Axel
%A Tichy, Diana
%A Bokemeyer, Carsten
%A Goldschmidt, Hartmut
%A Weisel, Katja C
%T Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial.
%J Leukemia
%V 36
%@ 1476-5551
%C London
%I Springer Nature
%M DKFZ-2021-02422
%P 885–888 
%D 2022
%Z 36, pages 885–888 (2022)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:34732857
%R 10.1038/s41375-021-01431-x
%U https://inrepo02.dkfz.de/record/177294